Roper Technologies (ROP) consistently makes the news as a strong performer in the stock market. It has been given a Moderate Buy recommendation by brokerages as its earnings are expected to grow. This solid growth stock has outperformed earnings expectations and consequently raised full-year guidance. Moreover, it has reported strong Q4 revenue and EBITDA growth. Various institutions like Wells Fargo & Company MN, UBS Group AG, and Nixon Peabody Trust Co. have increased their holdings of ROP. The firm made a significant $5.5 billion bid for Vertafore. ROP is also noted to have a steady balance sheet and its acquisitions have led to an increased profit forecast. Despite dips in its stocks, experts advise buying the dip. The firm's financial results have boosted the EPS estimates for Q2. ROP recently surpassed Q1 earnings estimates, with a robust rise in revenue. It has also been highlighted for its long-term compounding growth. Furthermore, Procare Solutions and Syntellis Performance Solutions are among the recent successful acquisitions by the company.
Roper Technologies ROP News Analytics from Sat, 10 Jun 2023 07:00:00 GMT to Sun, 26 May 2024 19:01:05 GMT -
Rating 8
- Innovation 6
- Information 9
- Rumor 7
